These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 16552473)

  • 1. Safety of nifedipine GITS in stable angina: the ACTION trial.
    Poole-Wilson PA; Kirwan BA; Vokó Z; de Brouwer S; van Dalen FJ; Lubsen J;
    Cardiovasc Drugs Ther; 2006 Feb; 20(1):45-54. PubMed ID: 16552473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial.
    Poole-Wilson PA; Lubsen J; Kirwan BA; van Dalen FJ; Wagener G; Danchin N; Just H; Fox KA; Pocock SJ; Clayton TC; Motro M; Parker JD; Bourassa MG; Dart AM; Hildebrandt P; Hjalmarson A; Kragten JA; Molhoek GP; Otterstad JE; Seabra-Gomes R; Soler-Soler J; Weber S;
    Lancet; 2004 Sep 4-10; 364(9437):849-57. PubMed ID: 15351192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Action: a 30,000 patient-years double-blind, placebo-controlled trial of nifedipine GITS in stable angina. ACTION Research Group.
    Lubsen J; Poole-Wilson PA
    Br J Clin Pract Suppl; 1997 Apr; 88():23-6. PubMed ID: 9519504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and current status of ACTION: A Coronary disease Trial Investigating Outcome with Nifedipine GITS. Gastro-Intestinal Therapeutic System.
    Lubsen J; Poole-Wilson PA; Pocock SJ; van Dalen FJ; Baumann J; Kirwan BA; Parker AB
    Eur Heart J; 1998 Aug; 19 Suppl I():I20-32. PubMed ID: 9743440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of long-acting dihydropyridine calcium channel blockers in hypertensive patients.
    Kloner RA; Vetrovec GW; Materson BJ; Levenstein M
    Am J Cardiol; 1998 Jan; 81(2):163-9. PubMed ID: 9591899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uric acid and other renal function parameters in patients with stable angina pectoris participating in the ACTION trial: impact of nifedipine GITS (gastro-intestinal therapeutic system) and relation to outcome.
    Ruilope LM; Kirwan BA; de Brouwer S; Danchin N; Fox KA; Wagener G; Segura J; Poole-Wilson PA; Lubsen J;
    J Hypertens; 2007 Aug; 25(8):1711-8. PubMed ID: 17620970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefits of nifedipine GITS in stable coronary artery disease: Further analysis of the "ACTION" database.
    Meredith PA; Elliott HL
    Adv Ther; 2010 May; 27(5):297-306. PubMed ID: 20490733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nifedipine GITS versus diltiazem in chronic stable angina: a randomised multicentre study.
    Zanolla L; Franceschini L; Rossi L; Ochan M; Amigoni S; Zardini P
    Br J Clin Pract Suppl; 1997 Apr; 88():27-35. PubMed ID: 9519505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with symptomatic stable angina and hypertension: the ACTION trial.
    Lubsen J; Wagener G; Kirwan BA; de Brouwer S; Poole-Wilson PA;
    J Hypertens; 2005 Mar; 23(3):641-8. PubMed ID: 15716708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug safety in cardiovascular disease: a call to ACTION.
    McMurray JJ
    Cardiovasc Drugs Ther; 2006 Feb; 20(1):9-10. PubMed ID: 16552471
    [No Abstract]   [Full Text] [Related]  

  • 11. Nifedipine gastrointestinal therapeutic system in stable angina pectoris. Results of a multicenter open-label crossover comparison with standard nifedipine.
    Vetrovec GW; Parker VE; Cole S; Procacci PM; Tabatznik B; Terry R
    Am J Med; 1987 Dec; 83(6B):24-9. PubMed ID: 3140660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of nifedipine in angina pectoris: a meta-analysis.
    Stason WB; Schmid CH; Niedzwiecki D; Whiting GW; Caubet JF; Cory D; Luo D; Ross SD; Chalmers TC
    Hypertension; 1999 Jan; 33(1):24-31. PubMed ID: 9931077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [ACTION: The clinical study of the month].
    Piérard LA
    Rev Med Liege; 2005 Jan; 60(1):61-3. PubMed ID: 15771319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modified-release nifedipine: a review of the use of modified-release formulations in the treatment of hypertension and angina pectoris.
    Croom KF; Wellington K
    Drugs; 2006; 66(4):497-528. PubMed ID: 16597165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose- and administration time-dependent effects of nifedipine gits on ambulatory blood pressure in hypertensive subjects.
    Hermida RC; Calvo C; Ayala DE; López JE; Rodríguez M; Chayán L; Mojón A; Fontao MJ; Fernández JR
    Chronobiol Int; 2007; 24(3):471-93. PubMed ID: 17612946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tracking coronary calcification and atherosclerotic lesions in patients with stable angina pectoris undergoing nifedipine therapy.
    Motro M; Kirwan BA; de Brouwer S; Poole-Wilson PA; Shemesh J;
    Cardiology; 2007; 107(3):165-71. PubMed ID: 16940720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlates of coronary angiography in patients with stable angina and geographical differences in its utilisation: the ACTION experience.
    Vokó Z; Danchin N; de Brouwer S; Kirwan BA; Poole-Wilson PA; Lubsen J;
    Int J Cardiol; 2010 Jan; 138(1):56-62. PubMed ID: 18845347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monotherapy with nifedipine GITS compared with atenolol in stable angina pectoris. The Working Group on Cardiovascular Research (WCN).
    de Vries RJ; Dunselman PH
    Br J Clin Pract Suppl; 1997 Apr; 88():6-9. PubMed ID: 9519501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained-release nifedipine: new indication. Angina: safer drugs are available.
    Prescrire Int; 1998 Jun; 7(35):71-3. PubMed ID: 10342920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of hypertension associated with stable angina pectoris: favourable interaction between new metoprolol formulation (OROS) and nifedipine.
    Di Somma S; de Divitiis M; Bertocchi F; Carotenuto A; Cudemo G; Petitto M; Napodano M; de Divitiis O
    Cardiologia; 1996 Jul; 41(7):635-43. PubMed ID: 8831181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.